Brief: AtriCure Q3 Adjusted EPS USD -0.17 Vs. IBES Estimate USD -0.19
29/10/2024 20:01
Oct 29 (Reuters) - AtriCure Q3 operating income USD -7.4 million vs. IBES estimate USD -8.11 million. * Q3 gross profit USD 86.8 million * Q3 gross margin 74.9% * Q3 revenue USD 115.9 million vs. IBES estimate USD 112.3 million * Q3 adjusted EBITDA USD 7.9 million vs. IBES estimate USD 6.61 million * outlook FY adjusted EBITDA USD 26-29 million * outlook FY adjusted EPS USD -0.8 to -0.74
Recent news on AtriCure
See all newsBrief: Inspire Medical Systems, Inc. Announces Appointment Of Seasoned Medical Device Executive Michael H. Carrel To Its Board Of Directors
AtriCure Inc reports results for the quarter ended June 30 - Earnings Summary
AtriCure Q2 revenue beats estimates
Brief: AtriCure Q2 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0
AtriCure Q1 revenue beats estimates, co raises 2026 outlook